Journal Title：Cancer Cell International

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques.

The journal focuses on novel cancer studies reporting data from biological experiments performed on cells grown in vitro, in two- or three-dimensional systems, and/or in vivo (animal experiments). These types of experiments have provided crucial data in many fields, from cell proliferation and transformation, to epithelial-mesenchymal interaction, to apoptosis, and host immune response to tumors.

Cancer Cell International also considers articles that focus on novel technologies or novel pathways in molecular analysis and on epidemiological studies that may affect patient care, as well as articles reporting translational cancer research studies where in vitro discoveries are bridged to the clinic. As such, the journal is interested in laboratory and animal studies reporting on novel biomarkers of tumor progression and response to therapy and on their applicability to human cancers.

《Cancer Cell International》發(fā)表有關(guān)癌細胞生物學各個方面的文章，這些文章主要來自（但不限于）使用細胞培養(yǎng)技術(shù)的工作。

該期刊專注于新型癌癥研究，報告在體外、二維或三維系統(tǒng)和/或體內(nèi)（動物實驗）生長的細胞上進行的生物實驗的數(shù)據(jù)。這些類型的實驗在許多領(lǐng)域提供了關(guān)鍵數(shù)據(jù)，從細胞增殖和轉(zhuǎn)化，到上皮-間質(zhì)相互作用，再到細胞凋亡和宿主對腫瘤的免疫反應(yīng)。

《Cancer Cell International》還考慮關(guān)注分子分析中的新技術(shù)或新途徑以及可能影響患者護理的流行病學研究的文章，以及報告將體外發(fā)現(xiàn)與臨床聯(lián)系起來的轉(zhuǎn)化癌癥研究的文章。因此，該期刊對實驗室和動物研究感興趣，這些研究報告了腫瘤進展和治療反應(yīng)的新型生物標志物及其對人類癌癥的適用性。

Cancer Cell International創(chuàng)刊于2001年，由BioMed Central出版商出版，收稿方向涵蓋ONCOLOGY全領(lǐng)域，此刊是該細分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細分領(lǐng)域中學術(shù)影響力較大，專業(yè)度認可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 約1月 ，影響因子指數(shù)5.3，該期刊近期被列入國際期刊預警名單，請廣大學者慎重選擇。